Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis a systematic review and meta-analysis of observational studies

Medicine (United States)

Volumn 95, Issue 8, 2016, Pages

  Peng, Ying ^a,b   Qi, Xingshun ^a   Guo, Xiaozhong ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE ON CHRONIC LIVER FAILURE; CHILD PUGH SCORE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LIVER CIRRHOSIS; LIVER SURGERY; META ANALYSIS; MODEL FOR END STAGE LIVER DISEASE SCORE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; COMPLICATION; MORTALITY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX;

HUMANS; LIVER CIRRHOSIS; OBSERVATIONAL STUDIES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84962542204     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002877     Document Type: Review

References (131)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
2. Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608.
3. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
4. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeDing oesophageal varices. Br J Surg. 1973;60:646-649.
5. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (Baltimore, MD). 2000;31:864-871.
6. Kamath PS, Kim WR, Advanced Liver Disease Study G. The model for end-stage liver disease (MELD). Hepatology (Baltimore, MD). 2007;45:797-805.
7. Bedreli S, Sowa JP, Gerken G, et al. Management of acute-onchronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis. Gut. 2016;65:357-358.
8. Trotter JF, Olson J, Lefkowitz J, et al. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant. 2007;7:1624-1628.
9. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-536.
10. An J, Kim KW, Han S, et al. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther. 2014;39:1418-1426.
11. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879-885.
12. Arif R, Seppelt P, Schwill S, et al. Predictive risk factors for patients with cirrhosis undergoing heart surgery. Ann Thorac Surg. 2012;94:1947-1952.
13. Attia KA, Ackoundou-N'guessan KC, N'Dri-Yoman AT, et al. Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol. 2008;14:286-291.
14. Augustin S, Muntaner L, Altamirano JT, et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol. 2009;7:1347-1354.
15. Bae WK, Lee JS, Kim NH, et al. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeDing patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month]. Korean J Hepatol. 2007;13:51-60.
16. Bang CS, Suk KT, Kim DJ. Clinical significance of hepatic venous pressure gradient measurement in the risk assessment of hepatocellular carcinoma. Hepatol Int. 2014;8:S387.
17. Befeler AS, Palmer DE, Hoffman M, et al. The safety of intraabdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg (Chicago, Ill: 1960). 2005;140:650-654; discussion 5.
18. Benedeto-Stojanov D, Nagorni A, Bjelakovic G, et al. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding. Vojnosanitet Pregl. 2009;66:724-728.
19. Bhise SB, Dias RJ, Mali KK. Prognostic value of the monoethylglycinexylidide test in alcoholic cirrhosis. Saudi J Gastroenterol. 2007;13:118-123.
20. Bie CQ, Yang DH, Tang SH, et al. Value of (Delta)MELD in evaluating the prognosis of patients with decompensated cirrhosis. World Chin J Digestol. 2007;15:3135-3139.
21. Bie CQ, Yang DH, Tang SH, et al. The value of model for endstage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res. 2009;39:779-785.
22. Biselli M, Dall'Agata M, Gramenzi A, et al. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. Liver Int. 2015;35:184-191.
23. Boin Ide F, Leonardi MI, Udo EY, et al. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term]. Arq Gastroenterol. 2008;45:275-283.
24. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52:134-139.
25. Boursier J, Cesbron E, Tropet AL, et al. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol. 2009;43:580-585.
26. Cerqueira RM, Andrade L, Correia MR, et al. Risk factors for inhospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2012;24:551-557.
27. Chan HL, Chim AM, Lau JT, et al. Evaluation of model for endstage liver disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol. 2006;101:1516-1523.
28. Chaurasia RK, Pradhan B, Chaudhary S, et al. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis. J Nepal Health Res Counc. 2013;11:9-16.
29. Chawla YK, Kashinath RC, Duseja A, et al. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores. J Clin Exp Hepatol. 2011;1:161-168.
30. Chen CH, Shih CM, Chou JW, et al. Outcome predictors of cirrhotic patients with spontaneous bacterial empyema. Liver Int. 2011;31:417-424.
31. Chen H, Bai M, Qi X, et al. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PloS One. 2013;8:e79637.
32. Cho HC, Jung HY, Sinn DH, et al. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score. Eur J Gastroenterol Hepatol. 2011;23:51-59.
33. Choi PC, Kim HJ, Choi WH, et al. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver Int. 2009;29:221-226.
34. Cholongitas E, Betrosian A, Senzolo M, et al. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol. 2008;23 ((8 Pt 1)):1223-1227.
35. Corneille MG, Nicholson S, Richa J, et al. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis. J Trauma. 2011;71:6-11.
36. Costa BP, Sousa FC, Serodio M, et al. Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases. World J Surg. 2009;33:1711-1719.
37. Das V, Boelle PY, Galbois A, et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med. 2010;38:2108-2116.
38. Degre D, Bourgeois N, Boon N, et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int. 2004;17:31-38.
39. Dhiman RK, Agrawal S, Gupta T, et al. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-onchronic liver failure and predicting outcome. World J Gastroenterol. 2014;20:14934-14941.
40. Duseja A, Choudhary NS, Gupta S, et al. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013;14:484-490.
41. Ecochard M, Boillot O, Guillaud O, et al. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transpl. 2011;25:755-765.
42. Emerson P, McPeake J, O'Neill A, et al. The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit. J Crit Care. 2014;29:1131.e1-1131.e6.
43. Fede G, Spadaro L, Tomaselli T, et al. Assessment of adrenocortical reserve in stable patients with cirrhosis. J Hepatol. 2011;54:243-250.
44. Fejfar T, Safka V, Hulek P, et al. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS]. Vnitr Lek. 2006;52:771-776.
45. Flores-Rendon AR, Gonzalez-Gonzalez JA, Garcia-Compean D, et al. Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding. Ann Hepatol. 2008;7:230-234.
46. Giannini E, Botta F, Fumagalli A, et al. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int. 2004;24:465-470.
47. Gomez EV, Bertot LC, Gra Oramas B, et al. Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. World J Gastroenterol. 2009;15:2768-2777.
48. Gotthardt D, Weiss KH, Baumgartner M, et al. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol. 2009;9:72.
49. Gotzberger M, Singer J, Kaiser C, et al. Intrarenal resistance index as a prognostic parameter in patients with liver cirrhosis compared with other hepatic scoring systems. Digestion. 2012;86:349-354.
50. Grunhage F, Rezori B, Neef M, et al. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death. Clin Gastroenterol Hepatol. 2008;6:1255-1262.
51. Hassan EA, Abd El-Rehim AS. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience. Arab J Gastroenterol. 2013;14:158-164.
52. Hoteit MA, Ghazale AH, Bain AJ, et al. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis. World J Gastroenterol. 2008;14:1774-1780.
53. Huo TI, Lin HC, Wu JC, et al. Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction. Transplantation. 2005;80:1414-1418.
54. Huo TI, Lin HC, Wu JC, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl. 2006;12:65-71.
55. Huo TI, Wu JC, Lin HC, et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol. 2005;42:826-832.
56. Hyun JJ, Seo YS, Yoon E, et al. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virusrelated decompensated cirrhosis. Liver Int. 2012;32:656-664.
57. Ishizu Y, Kuzuya T, Honda T, et al. A simple scoring system using MELD-Na and the stage of hepatocellular carcinoma for prediction of early mortality after acute variceal bleeDing in patients with liver cirrhosis. Hepatology (Baltimore, MD). 2014; 60:1193A.
58. Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-onchronic liver failure. J Hepatol. 2014;61:1038-1047.
59. Jiang CM, Xie W, Wang ZH. Prognostic evaluation for patients with decompensated hepatic cirrhosis. J Dalian Med Univ. 2009;31:67-70.
60. Jiang J, Ye JJ, Liu GY, et al. Visualization of the biliary ducts on contrast enhanced MR cholangiography with Gd-EOB-DTPA: Relation with liver function in patients with liver cirrhosis. Chin J Med Imaging Technol. 2013;29:765-769.
61. Kalabay L, Graf L, Voros K, et al. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores. BMC Gastroenterol. 2007;7:15.
62. Khan R, Abid S, Jafri W, et al. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection. J Coll Physicians Surg Pak. 2009;19:694-698.
63. Kim DH, Kim SH, Kim KS, et al. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices. ANZ J Surg. 2014;84:832-836.
64. Kim SY, Yim HJ, Lee J, et al. [Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis]. Korean J Gastroenterol. 2007;50:92-100.
65. Kim TY, Kim MY, Sohn IH, et al. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci. 2014;29:1253-1259.
66. Koo JK, Kim JH, Choi YJ, et al. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis. J Gastroenterol Hepatol. 2013;28:1209-1216.
67. Krishnan A. Assessment of an optimal prognostic system for predicting mortality in patients awaiting liver transplantation: CTP vs meld. HPB. 2013;15:15.
68. Kwon HJ, Koo KH, Han BH, et al. The prognostic value of hyponatremia in a well-defined population of patients with ascites due to cirrhosis. Hepatol Int. 2014;8:S386.
69. Lee JY, Lee JH, Kim SJ, et al. [Comparison of predictive factors related to the mortality and rebleeDing caused by variceal bleeding: Child-Pugh score, MELD score, and Rockall score]. J Hepatol. 2002;8:458-464.
70. Lee M, Lee JH, Oh S, et al. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver Int. 2015;35:46-57.
71. Levesque E, Hoti E, Azoulay D, et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol. 2012;56:95-102.
72. Lim LG, Tan XX, Woo SJ, et al. Risk factors for mortality in cirrhotic patients with sepsis. Hepatol Int. 2011;5:800-807.
73. Lim SG, Lim LG, Xuan X, et al. Risk factors for mortality in cirrhotic patients with sepsis. Hepatology (Baltimore, MD). 2009;50:454A.
74. Lv XH, Liu HB, Wang Y, et al. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. J Gastroenterol Hepatol. 2009;24:1547-1553.
75. Mallaiyappan M, Sawalakhe NR, Sasidharan M, et al. Retrospective and prospective validation of model for end-stage liver disease (MELD) score in predicting mortality in patients of alcoholic liver disease. Trop Gastroenterol. 2013;34:252-258.
76. Mishra P, Desai N, Alexander J, et al. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience. J Gastroenterol Hepatol. 2007;22:1232-1235.
77. Moreno JP, Grandclement E, Monnet E, et al. Plasma copeptin, a possible prognostic marker in cirrhosis. Liver Int. 2013;33:843-851.
78. Mouelhi L, Ben Hammouda I, Salem M, et al. Hospital mortality in cirrhotic patients admitted in intensive care unit: prognosis factors and impact of gravity scores. J Afr d'Hepato-Gastroenterol. 2010;4:17-21.
79. Nunes D, Fleming C, Offner G, et al. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol. 2010;105:1346-1353.
80. Olmez S, Gumurdulu Y, Tas A, et al. Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study. Ann Hepatol. 2012;11:513-518.
81. Orloff MJ, Vaida F, Isenberg JI, et al. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeDing esophageal varices in cirrhosis. J Surg Res. 2012;178:139-146.
82. Papatheodoridis GV, Cholongitas E, Dimitriadou E, et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol. 2005;11:3099-3104.
83. Park SH, Suk KT, Kim EJ, et al. Prognostic significance of the hemodynamic and clinical staging in the prediction of mortality in patients with chronic liver disease. Hepatology (Baltimore, MD). 2014;60:1182A-1183A.
84. Peng Y, Qi X, Dai J, et al. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeDing in liver cirrhosis. Int J Clin Exp Med. 2015;8:751-757.
85. Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol. 2004;2:1123-1128.
86. Radha Krishna Y, Saraswat VA, Das K, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29:392-398.
87. Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, et al. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions. Arch Iran Med. 2014;17:118-121.
88. Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, et al. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation. Transpl Proc. 2009;41:3114-3116.
89. Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412-431e3.
90. Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481-488.
91. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol. 2002;36:494-500.
92. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol. 2003;98:1167-1174.
93. Seamon MJ, Franco MJ, Stawicki SP, et al. Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP. J Trauma. 2010;69:568-573.
94. Sempere L, Palazon JM, Sanchez-Paya J, et al. Assessing the shortand long-term prognosis of patients with cirrhosis and acute variceal bleeding. Rev Esp Enferm Dig. 2009;101:236-248.
95. Serra MA, Puchades MJ, Rodriguez F, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scand J Gastroenterol. 2004;39:1149-1153.
96. Serste T, Gustot T, Rautou PE, et al. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol. 2012;57:274-280.
97. Shaikh S, Ghani H, Memon S, et al. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver. J Coll Physicians Surg. 2010;20:432-435.
98. Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187.
99. Song CS, Yoon MY, Kim HJ, et al. [Usefulness of model for endstage liver disease score for predicting mortality after intraabdominal surgery in patients with liver cirrhosis in a single hospital]. Korean J Gastroenterol. 2011;57:340-345.
100. Song DS, Kim DJ, Kim TY, et al. The usefulness of prognostic factors of acute-on chronic liver failure in patients with liver cirrhosis: a multicenter, retrospective cohort study in Korea (KACLiF Study). Hepatology (Baltimore, MD). 2014;60:552A-553A.
101. Stewart CA, Malinchoc M, Kim WR, et al. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007;13:1366-1371.
102. Su CW, Chan CC, Hung HH, et al. Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis. J Clin Gastroenterol. 2009;43:876-883.
103. Suk KT, Bang CS, Lee YS, et al. Diagnostic significance of hepatic venous pressure gradient in the prediction of hepatocellular carcinoma. J Hepatol. 2014;60:S261.
104. Suman A, Barnes DS, Zein NN, et al. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol. 2004;2:719-723.
105. Tacke F, Fiedler K, Trautwein C. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol. 2007;42:374-382.
106. Takaya H, Uemura M, Fujimura Y, et al. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. Hepatol Res. 2012;42:459-472.
107. Tas A, Akbal E, Beyazit Y, et al. Serum lactate level predict mortality in elderly patients with cirrhosis. Wien Klin Wochenschr. 2012;124:520-525.
108. Tas A, Koklu S, Beyazit Y, et al. Thyroid hormone levels predict mortality in intensive care patients with cirrhosis. Am J Med Sci. 2012;344:175-179.
109. Teng W, Chen WT, Ho YP, et al. Predictors of mortality within 6 weeks after treatment of gastric variceal bleeDing in cirrhotic patients. Medicine (United States). 2014;93:e321.
110. Theocharidou E, Pieri G, Mohammad AO, et al. The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score. Am J Gastroenterol. 2014;109:554-562.
111. Thielmann M, Mechmet A, Neuhauser M, et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. Eur J Cardiothorac Surg. 2010;38:592-599.
112. Tu KH, Jenq CC, Tsai MH, et al. Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients. Shock (Augusta, GA). 2011;36:445-450.
113. Tzeng WS, Wu RH, Lin CY, et al. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol. 2009;10:481-489.
114. Vanhuyse F, Maureira P, Portocarrero E, et al. Cardiac surgery in cirrhotic patients: results and evaluation of risk factors. Eur J Cardiothorac Surg. 2012;42:293-299.
115. Velayutham V, Sathyanesan J, Krishnan A, et al. Variation of meld vs child pugh score for predicting survival in patients in waiting list for liver transplantation. Liver Transpl. 2012;18:S220.
116. Viasus D, Garcia-Vidal C, Castellote J, et al. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine. 2011;90:110-118.
117. Wang J, Wang AJ, Li BM, et al. MELD-Na: effective in predicting rebleeDing in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy. J Clin Gastroenterol. 2014;48:870-877.
118. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96.
119. Wu SJ, Yan HD, Zheng ZX, et al. Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-onchronic hepatitis B liver failure: a prospective cohort study. Medicine. 2015;94:e403.
120. Xie YD, Feng B, Gao Y, et al. Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis. Hepatobiliary Pancreat Dis Int. 2013;12:594-601.
121. Xiong WJ, Liu F, Zhao ZX, et al. Application of an end-stage liver disease model in prediction of prognosis in patients with liver cirrhosis. World Chin J Digestol. 2004;12:1159-1162.
122. Zapata R, Innocenti F, Sanhueza E, et al. Predictive models in cirrhosis: correlation with the final results and costs of liver transplantation in Chile. Transpl Proc. 2004;36:1671-1672.
123. Zhang F, Zhuge Y, Zou X, et al. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2014;26:853-860.
124. Zhang J, Lu F, Ouyang C, et al. [Respective analysis of dead patients with cirrhosis by Child-Pugh score and model of end-stage liver disease score]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37:1021-1026.
125. Zhang J, Ye L, Zhang J, et al. MELD scores and Child-Pugh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholithiasis: a retrospective cohort study. Medicine. 2015;94:e433.
126. Zhang JY, Zhang FK, Wang BE, et al. [The prognostic value of end-stage liver disease model in liver cirrhosis]. Zhonghua Nei Ke Za Zhi. 2005;44:822-824.
127. Zhang QB, Chen YT, Lian GD, et al. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clin Res Hepatol Gastroenterol. 2012;36:583-591.
128. Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol. 2011;9:351-356e3.
129. Cholongitas E, Papatheodoridis GV, Vangeli M, et al. Systematic review: The model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther. 2005;22:1079-1089.
130. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42 (SUPPL. 1):S100-S107.
131. Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008;28:110-122.